Direct oral anticoagulants versus vitamin K antagonists in the treatment of left ventricular thrombosis: when off label becomes routine
Minerva Cardiol Angiol
.
2022 Dec;70(6):663-665.
doi: 10.23736/S2724-5683.22.06047-1.
Authors
Francesca M DI Muro
1
,
Giulio Russo
2
,
Carlo DI Mario
1
,
Daniela Pedicino
3
4
Affiliations
1
Unit of Structural Interventional Cardiology, Department of Clinical and Experimental Medicine, Careggi University Hospital, Florence, Italy.
2
Department of Biomedicine and Prevention, Policlinico Tor Vergata, Tor Vergata University, Rome, Italy.
3
Department of Cardiovascular Sciences, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy - danialla@gmail.com.
4
Department of Cardiovascular and Pulmonary Sciences, Sacred Heart Catholic University, Rome, Italy.
PMID:
36700666
DOI:
10.23736/S2724-5683.22.06047-1
No abstract available
Publication types
Comment
MeSH terms
Anticoagulants / adverse effects
Heart Diseases*
Humans
Off-Label Use
Thrombosis* / drug therapy
Vitamin K / therapeutic use
Substances
Anticoagulants
Vitamin K